Cleerly ISCHEMIA vs Stethee Pro 1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by M3DICINE

AI Verdict

Cleerly ISCHEMIA focuses on advanced diagnostic imaging analysis of CCTA scans to assess coronary artery disease, including ischemia likelihood and plaque characteristics. In contrast, Stethee Pro 1 provides real-time cardiac and respiratory vital sign analysis via an AI-enabled digital stethoscope for immediate point-of-care diagnostics and remote monitoring. While both are AI tools in cardiology, they address different diagnostic needs and utilize fundamentally distinct data inputs and methodologies.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you require a comprehensive, non-invasive assessment of coronary artery disease, including detailed plaque characterization and vessel-level ischemia likelihood, derived from CCTA scans. This tool is ideal for physicians needing precise anatomical and functional insights to guide personalized diagnosis and treatment planning for heart disease.

View Cleerly ISCHEMIA →

Choose Stethee Pro 1 if…

Choose Stethee Pro 1 if you need real-time, AI-enabled auscultation and vital sign analysis for cardiac and respiratory conditions, especially in point-of-care or remote monitoring scenarios. This wireless digital stethoscope system is best suited for quick diagnostic insights, telemedicine, and secure sharing of heart and lung sounds.

View Stethee Pro 1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly ISCHEMIA Stethee Pro 1
Pricing Unknown $499 usd
Deployment Web-based solution Cloud, Mobile
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Stethee Pro 1

Stethee Pro 1 offers a more immediate and intuitive user experience due to its physical wireless device, mobile application, and real-time feedback capabilities for direct patient interaction and data capture. Cleerly ISCHEMIA, while providing comprehensive web-based reports, operates within a more specialized diagnostic workflow focused on post-scan analysis. User reviews for Stethee Pro 1 often highlight its ease of use and convenience.

Clinical Value

Cleerly ISCHEMIA

Cleerly ISCHEMIA provides advanced AI analysis of CCTA scans to non-invasively determine ischemia likelihood, estimate FFR, and characterize coronary plaque, addressing a complex and critical diagnostic pathway in cardiology. This has the potential to guide more precise and less invasive treatment decisions for coronary artery disease. Stethee Pro 1 enhances traditional auscultation with digital and AI capabilities, which is valuable, but Cleerly's impact on high-level diagnostic and treatment planning for a life-threatening condition is arguably greater.

Pricing & Value

Stethee Pro 1

Stethee Pro 1 offers transparent pricing for its core device ($499), allowing for a clearer initial understanding of the investment, even though the subscription cost for the web portal is not detailed. Cleerly ISCHEMIA's pricing is entirely opaque, stating 'contact for details' and 'varies by provider,' which makes it difficult for potential users to assess its value proposition without direct engagement.

Enterprise Readiness

Cleerly ISCHEMIA

Cleerly ISCHEMIA explicitly confirms a Business Associate Agreement (BAA) and details enterprise-grade deployment methods such as data transfer via VPN or virtual appliance (Cleerly Proxy), along with integration with PowerScribe via API. These features demonstrate a comprehensive approach to enterprise deployment, data security, and workflow integration. While Stethee Pro 1 is HIPAA compliant and 'likely' has a BAA, its enterprise integration details are less specific.

Innovation

Tie

Both tools demonstrate significant innovation. Cleerly ISCHEMIA applies advanced AI to complex CCTA imaging data for non-invasive FFR estimation and detailed plaque characterization, pushing the boundaries of cardiac diagnostic imaging. Stethee Pro 1 innovatively transforms a traditional stethoscope into an AI-enabled, wireless, digital system with real-time analysis, advanced amplification, and environmental data tagging, redefining a fundamental diagnostic tool.

Support & Docs

Stethee Pro 1

M3DICINE's website for Stethee Pro 1 explicitly features a dedicated 'Support' section with readily accessible FAQs and user manuals, indicating a transparent and immediate approach to user documentation. While Cleerly's website mentions a 'Support' section and 'Cleerly University' for education, the direct availability of specific user manuals and FAQs for Stethee Pro 1 suggests a more robust and easily discoverable self-service support offering.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly ISCHEMIA Stethee Pro 1
Name Cleerly ISCHEMIA Stethee Pro 1
Company Cleerly M3DICINE Pty Ltd.
Tagline AI-Powered Precision for Non-Invasive Ischemia Detection The World's First AI-Enabled Wireless Stethoscope System for Advanced Cardiac and Respiratory Diagnostics.
Primary Function Analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level. AI-enabled wireless digital stethoscope system providing real-time cardiac and respiratory vital sign analysis.
Key Feature Example 1 AI-enabled CCTA analysis AI-enabled wireless digital stethoscope system
Key Feature Example 2 Non-invasive fractional flow reserve (FFR) estimation Captures cardiac and respiratory vital signs in 20 seconds

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Stethee Pro 1.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly ISCHEMIA is an AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding in personalized diagnosis and treatment planning for heart disease. Stethee Pro 1 is an AI-enabled wireless digital stethoscope system that provides real-time cardiac and respiratory vital sign analysis, advanced amplification, and secure data sharing for enhanced diagnostics and telemedicine.
Cleerly ISCHEMIA uses AI for CCTA analysis, non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, and coronary plaque characterization. Stethee Pro 1 incorporates AI to capture and analyze cardiac and respiratory vital signs, providing real-time visualization of heart and lung sounds, and measuring various physiological parameters.
Cleerly ISCHEMIA generates comprehensive interactive web-based reports, 3D digital models of coronary arteries, and assessments of plaque volume, type, location, and stenosis severity. Stethee Pro 1 offers real-time visualization of heart (PCG, AIDA Cycle, AIDA Energy) and lung sounds (spectrogram), and measures systole, diastole, heart cycle durations, and respiration rate.
Cleerly ISCHEMIA primarily targets Cardiology and Radiology specialties due to its focus on CCTA analysis for heart disease. Stethee Pro 1 caters to Cardiology, Emergency Medicine, and Pulmonology, given its capabilities in cardiac and respiratory vital sign analysis.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.